Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight Report 2021-2026 Featuring Acopedia, Takeda Pharma, TC Biopharma and Adapate Therapeutics
May 20, 2021 05:58 ET | Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting
May 19, 2021 17:02 ET | Rubius Therapeutics
CAMBRIDGE, Mass., May 19, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 19, 2021 05:06 ET | Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
May 13, 2021 16:02 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
May 13, 2021 08:00 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces the filing of its SEC Form...
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET | Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
CrannMed partners with leading Digital Research Organization, Meditrial to obtain “Breakthrough Device Designation” by the FDA for its innovative Knee Osteoarthritis Therapy
May 13, 2021 06:00 ET | Meditrial
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Meditrial Inc, a leading Global Digitally Driven Research Organization, is pleased to announce its successful collaboration with CrannMed Limited in...
Global Clinical Trials Markets, 2016-2020 & 2021-2026 - Digitization of Clinical Trials is Anticipated to Propel the Growth
May 11, 2021 05:08 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study...
RYAH logo.jpg
RYAH Group, Inc. Enters New Zealand Market, signs Distribution Agreement with Medical Kiwi Ltd
May 10, 2021 09:29 ET | Potbotics, Inc. o/a RYAH
New York, May 10, 2021 (GLOBE NEWSWIRE) -- via InvestorWire-- RYAH Group, Inc’s (CSE:RYAH) wholly owned subsidiary, RYAH Medtech, Inc., a medical device, data and technology company announced today...
Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
May 10, 2021 07:00 ET | Vineti
New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced therapy clinical...